The inhibition of ERK1/2 with U0126 led to reduced MMP-9 expression and decreased cellular invasiveness, supporting the direct role of ERK1/2 in regulating iCCA tumor invasion [21]. The gene discussed is MAPK3; the disease is neoplasm.